{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:07:27Z","timestamp":1791400047708,"version":"4.3.3"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>\n                      To give an overview about the expanding spectrum of autoinflammatory diseases due to mutations in proline-serine-threonine phosphatase-interacting protein 1 (\n                      <jats:italic toggle=\"yes\">PSTPIP1<\/jats:italic>\n                      ) and new insights into their pathogenesis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>\n                      In addition to classical pyogenic sterile arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome,\n                      <jats:italic toggle=\"yes\">PSTPIP1<\/jats:italic>\n                      -associated myeloid-related proteinemia inflammatory (PAMI) syndrome has been described as a distinct clinical phenotype of\n                      <jats:italic toggle=\"yes\">PSTPIP1<\/jats:italic>\n                      -associated inflammatory diseases (PAID) and other entities are emerging. In addition to dysregulation of IL-1\u00df release from activated PAPA monocytes that requires NLR family, pyrin domain containing 3 (NLRP3),\n                      <jats:italic toggle=\"yes\">PSTPIP1<\/jats:italic>\n                      mutations have an general impact on cellular dynamics of cells of the innate immune system. In addition, overwhelming expression and release of the alarmins myeloid-related protein (MRP) 8 and 14 by activated phagocytes and keratinocytes, which promote innate immune mechanisms in a Toll like receptor (TLR) 4-dependent manner, are a characteristic feature of these diseases and form a positive feed-back mechanism with IL-1\u00df.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>\n                      Autoinflammatory diseases due to\n                      <jats:italic toggle=\"yes\">PSTPIP1<\/jats:italic>\n                      mutations are not restricted to the classical PAPA phenotype but might present with other distinct clinical features. MRP8\/14 serum levels are a hallmark of PAPA and PAMI and can be used as screening tool to initiate targeted genetic testing in suspected cases. The feedback mechanism of IL-1\u00df and MRP-alarmin release may offer novel targets for future therapeutic approaches.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/bor.0000000000000314","type":"journal-article","created":{"date-parts":[[2016,7,27]],"date-time":"2016-07-27T20:05:57Z","timestamp":1469649957000},"page":"550-559","source":"Crossref","is-referenced-by-count":76,"title":["Alarming consequences \u2013 autoinflammatory disease spectrum due to mutations in proline-serine-threonine phosphatase-interacting protein 1"],"prefix":"10.1097","volume":"28","author":[{"given":"Dirk","family":"Holzinger","sequence":"first","affiliation":[{"name":"Department of Paediatric Rheumatology and Immunology, University Children's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Roth","sequence":"additional","affiliation":[{"name":"Institute of Immunology, University Hospital Muenster, Muenster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230828","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0025-6196(11)63565-9","article-title":"A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome","volume":"72","author":"Lindor","year":"1997","journal-title":"Mayo Clin Proc"},{"key":"R2-20230828","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1002\/1529-0131(200009)43:9<2041::AID-ANR15>3.0.CO;2-G","article-title":"Localization of a gene for familial recurrent arthritis","volume":"43","author":"Wise","year":"2000","journal-title":"Arthritis Rheum"},{"key":"R3-20230828","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1086\/302866","article-title":"Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome maps to chromosome 15q","volume":"66","author":"Yeon","year":"2000","journal-title":"Am J Hum Genet"},{"key":"R4-20230828","doi-asserted-by":"crossref","first-page":"5898","DOI":"10.4049\/jimmunol.176.10.5898","article-title":"CD2BP1 modulates CD2-dependent T cell activation via linkage to protein tyrosine phosphatase (PTP)-PEST","volume":"176","author":"Yang","year":"2006","journal-title":"J Immunol"},{"key":"R5-20230828","doi-asserted-by":"crossref","first-page":"13501","DOI":"10.1073\/pnas.2135380100","article-title":"Pyrin binds the PSTPIP1\/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway","volume":"100","author":"Shoham","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"R6-20230828","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/hmg\/11.8.961","article-title":"Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder","volume":"11","author":"Wise","year":"2002","journal-title":"Hum Mol Genet"},{"key":"R7-20230828","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.molcel.2007.08.029","article-title":"Pyrin activates the ASC pyroptosome in response to engagement by autoinflammatory PSTPIP1 mutants","volume":"28","author":"Yu","year":"2007","journal-title":"Mol Cell"},{"key":"R8-20230828","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jpeds.2004.08.001","article-title":"Abnormal production of tumor necrosis factor (TNF) \u2013 alpha and clinical efficacy of the TNF inhibitor etanercept in a patient with PAPA syndrome","volume":"145","author":"Cortis","year":"2004","journal-title":"J Pediatr"},{"key":"R9-20230828","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00124743-200210000-00009","article-title":"Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome) associated with hypogammaglobulinemia and elevated serum tumor necrosis factor-alpha levels","volume":"8","author":"Edrees","year":"2002","journal-title":"J Clin Rheumatol"},{"key":"R10-20230828","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1525-1470.2005.22320.x","article-title":"Dramatic improvement of pyoderma gangrenosum with infliximab in a patient with PAPA syndrome","volume":"22","author":"Stichweh","year":"2005","journal-title":"Pediatr Dermatol"},{"key":"R11-20230828","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/rheumatology\/keh479","article-title":"Anakinra for flares of pyogenic arthritis in PAPA syndrome","volume":"44","author":"Dierselhuis","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"R12-20230828","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/2013.jamadermatol.717","article-title":"Identification of a homozygous PSTPIP1 mutation in a patient with a PAPA-like syndrome responding to canakinumab treatment","volume":"149","author":"Geusau","year":"2013","journal-title":"JAMA Dermatol"},{"key":"R13-20230828","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.jaci.2015.04.016","article-title":"Single amino acid charge switch defines clinically distinct proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1)-associated inflammatory diseases","volume":"136","author":"Holzinger","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"R14-20230828","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1001\/jamadermatol.2013.2907","article-title":"Pyogenic arthritis, pyoderma gangrenosum, acne, and hidradenitis suppurativa (PAPASH): a new autoinflammatory syndrome associated with a novel mutation of the PSTPIP1 gene","volume":"149","author":"Marzano","year":"2013","journal-title":"JAMA Dermatol"},{"key":"R15-20230828","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.1074\/jbc.M112.443077","article-title":"Inflammation in mice ectopically expressing human pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome-associated PSTPIP1 A230T mutant proteins","volume":"288","author":"Wang","year":"2013","journal-title":"J Biol Chem"},{"key":"R16-20230828","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1365-2133.2009.09404.x","article-title":"Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra","volume":"161","author":"Brenner","year":"2009","journal-title":"Br J Dermatol"},{"key":"R17-20230828","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.3899\/jrheum.140060","article-title":"Osteolytic lesion in PAPA syndrome responding to antiinterleukin 1 treatment","volume":"41","author":"Caorsi","year":"2014","journal-title":"J Rheumatol"},{"key":"R18-20230828","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1002\/art.34332","article-title":"Brief report: genotype, phenotype, and clinical course in five patients with PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne)","volume":"64","author":"Demidowich","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R19-20230828","first-page":"956","article-title":"A novel de novo PSTPIP1 mutation in a boy with pyogenic arthritis, pyoderma gangrenosum, acne (PAPA) syndrome","volume":"32","author":"Fathalla","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"R20-20230828","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kew031","article-title":"Disease activity accounts for long-term efficacy of IL-1 blockers in pyogenic sterile arthritis pyoderma gangrenosum and severe acne syndrome","author":"Omenetti","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"R21-20230828","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00105-007-1331-z","article-title":"Pyogenic arthritis, pyoderma gangrenosum and acne syndrome (PAPA syndrome)","volume":"58","author":"Renn","year":"2007","journal-title":"Hautarzt"},{"key":"R22-20230828","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1136\/ard.2009.126185","article-title":"Variable expression and treatment of PAPA syndrome","volume":"70","author":"Schellevis","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R23-20230828","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2174\/138920210793175921","article-title":"Clinical, molecular, and genetic characteristics of PAPA syndrome: a review","volume":"11","author":"Smith","year":"2010","journal-title":"Curr Genomics"},{"key":"R24-20230828","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1093\/rheumatology\/kei178","article-title":"Peculiarities of PAPA syndrome","volume":"45","author":"Tallon","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"R25-20230828","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/RHU.0b013e3181e969b9","article-title":"Clinical efficacy of etanercept for treatment of PAPA syndrome","volume":"16","author":"Tofteland","year":"2010","journal-title":"J Clin Rheumatol"},{"key":"R26-20230828","first-page":"452","article-title":"Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome) with E250K mutation in CD2BP1 gene treated with the tumor necrosis factor inhibitor adalimumab","volume":"30","author":"Lee","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"R27-20230828","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.semarthrit.2015.02.012","article-title":"Novel PSTPIP1 gene mutation in a patient with pyogenic arthritis, pyoderma gangrenosum and acne (PAPA) syndrome","volume":"45","author":"Lindwall","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"R28-20230828","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/ced.12585","article-title":"Pyoderma gangrenosum, acne and ulcerative colitis in a patient with a novel mutation in the PSTPIP1 gene","volume":"40","author":"Zeeli","year":"2015","journal-title":"Clin Exp Dermatol"},{"key":"R29-20230828","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1136\/annrheumdis-2011-200549","article-title":"An international registry on autoinflammatory diseases: the Eurofever experience","volume":"71","author":"Toplak","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"R30-20230828","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/humu.20080","article-title":"Infevers: an evolving mutation database for auto-inflammatory syndromes","volume":"24","author":"Touitou","year":"2004","journal-title":"Hum Mutat"},{"key":"R31-20230828","doi-asserted-by":"crossref","DOI":"10.1136\/neurintsurg-2015-011917.120","article-title":"Cerebral vascular findings in PAPA syndrome: cerebral arterial vasculopathy or vasculitis and a posterior cerebral artery dissecting aneurysm","author":"Khatibi","year":"2015","journal-title":"J Neurointerv Surg"},{"key":"R32-20230828","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jaad.2010.12.025","article-title":"Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) \u2013 a new autoinflammatory syndrome distinct from PAPA syndrome","volume":"66","author":"Braun-Falco","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"R33-20230828","article-title":"PSTPIP1 Gene mutation in a pyoderma gangrenosum, acne and suppurative hidradenitis (PASH) syndrome","author":"Calderon-Castrat","year":"2015","journal-title":"Br J Dermatol"},{"key":"R34-20230828","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1365-2230.2011.04137.x","article-title":"Mutations in the PSTPIP1 gene and aberrant splicing variants in patients with pyoderma gangrenosum","volume":"36","author":"Nesterovitch","year":"2011","journal-title":"Clin Exp Dermatol"},{"key":"R35-20230828","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.immuni.2011.02.020","article-title":"Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1beta activation and severe autoinflammation in mice","volume":"34","author":"Chae","year":"2011","journal-title":"Immunity"},{"key":"R36-20230828","doi-asserted-by":"crossref","first-page":"11378","DOI":"10.1074\/jbc.M112.448795","article-title":"Ribotoxic stress through p38 mitogen-activated protein kinase activates in vitro the human pyrin inflammasome","volume":"288","author":"Yu","year":"2013","journal-title":"J Biol Chem"},{"key":"R37-20230828","doi-asserted-by":"crossref","first-page":"e6147","DOI":"10.1371\/journal.pone.0006147","article-title":"Pyrin modulates the intracellular distribution of PSTPIP1","volume":"4","author":"Waite","year":"2009","journal-title":"PLoS One"},{"key":"R38-20230828","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1074\/jbc.M106428200","article-title":"PSTPIP is a substrate of PTP-PEST and serves as a scaffold guiding PTP-PEST toward a specific dephosphorylation of WASP","volume":"277","author":"Cote","year":"2002","journal-title":"J Biol Chem"},{"key":"R39-20230828","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1084\/jem.20030976","article-title":"Fyn and PTP-PEST-mediated regulation of Wiskott-Aldrich syndrome protein (WASp) tyrosine phosphorylation is required for coupling T cell antigen receptor engagement to WASp effector function and T cell activation","volume":"199","author":"Badour","year":"2004","journal-title":"J Exp Med"},{"key":"R40-20230828","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1002\/cbin.10514","article-title":"Pyrin-PSTPIP1 colocalises at the leading edge during cell migration","volume":"39","author":"Akkaya-Ulum","year":"2015","journal-title":"Cell Biol Int"},{"key":"R41-20230828","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1091\/mbc.e08-02-0225","article-title":"The PCH family member proline-serine-threonine phosphatase-interacting protein 1 targets to the leukocyte uropod and regulates directed cell migration","volume":"19","author":"Cooper","year":"2008","journal-title":"Mol Biol Cell"},{"key":"R42-20230828","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1002\/art.27521","article-title":"Impaired podosome formation and invasive migration of macrophages from patients with a PSTPIP1 mutation and PAPA syndrome","volume":"62","author":"Cortesio","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R43-20230828","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1182\/blood-2013-07-516948","article-title":"The F-BAR protein PSTPIP1 controls extracellular matrix degradation and filopodia formation in macrophages","volume":"123","author":"Starnes","year":"2014","journal-title":"Blood"},{"key":"R44-20230828","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1172\/JCI62423","article-title":"Alarmins: awaiting a clinical response","volume":"122","author":"Chan","year":"2012","journal-title":"J Clin Invest"},{"key":"R45-20230828","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1189\/jlb.1008647","article-title":"The endogenous Toll-like receptor 4 agonist S100A8\/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer","volume":"86","author":"Ehrchen","year":"2009","journal-title":"J Leukoc Biol"},{"key":"R46-20230828","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nm.2150","article-title":"The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8+ T cells","volume":"16","author":"Loser","year":"2010","journal-title":"Nat Med"},{"key":"R47-20230828","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/nm1638","article-title":"Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock","volume":"13","author":"Vogl","year":"2007","journal-title":"Nat Med"},{"key":"R48-20230828","doi-asserted-by":"crossref","first-page":"575","DOI":"10.4049\/jimmunol.1401085","article-title":"Transcriptome assessment reveals a dominant role for TLR4 in the activation of human monocytes by the alarmin MRP8","volume":"194","author":"Fassl","year":"2015","journal-title":"J Immunol"},{"key":"R49-20230828","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1182\/blood-2004-02-0446","article-title":"MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes","volume":"104","author":"Vogl","year":"2004","journal-title":"Blood"},{"key":"R50-20230828","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/art.24349","article-title":"The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1beta form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis","volume":"60","author":"Frosch","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R51-20230828","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/rheumatology\/kem271","article-title":"New insights in systemic juvenile idiopathic arthritis \u2013 from pathophysiology to treatment","volume":"47","author":"Frosch","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"R52-20230828","doi-asserted-by":"crossref","first-page":"9496","DOI":"10.1074\/jbc.272.14.9496","article-title":"Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway","volume":"272","author":"Rammes","year":"1997","journal-title":"J Biol Chem"},{"key":"R53-20230828","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1074-7613(02)00516-2","article-title":"The Wiskott-Aldrich syndrome protein acts downstream of CD2 and the CD2AP and PSTPIP1 adaptors to promote formation of the immunological synapse","volume":"18","author":"Badour","year":"2003","journal-title":"Immunity"},{"key":"R54-20230828","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1111\/febs.12912","article-title":"Proline-serine-threonine phosphatase interacting protein 1 inhibition of T-cell receptor signaling depends on its SH3 domain","volume":"281","author":"Marcos","year":"2014","journal-title":"FEBS J"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00002281-201609000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T01:31:04Z","timestamp":1693186264000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201609000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000314","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}